R. Moscicki

S. Telian, M. Weisman, M. Espeland, 2009, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis

L. Trentin, R. Moscicki, J. Kurnick, 1992, Clinical and experimental immunology.

Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.

R. Colvin, A. Bhan, R. Moscicki, 1984, Journal of immunology.

Immunopathology of pityriasis lichenoides acuta.

M. Mihm, A. Bhan, R. Moscicki, 1984, Journal of the American Academy of Dermatology.

T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation.

R. Moscicki, J. Kurnick, C. Leary, 1983, Clinical immunology and immunopathology.

Lymphedema, lymphocytic myocarditis, and sarcoidlike granulomatosis. Manifestations of Whipple's disease.

J. Fallon, J. Southern, G. Dickersin, 1989, JAMA.

Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease.

W. H. Hall, Robin E Berman, F. Collins, 1996, JAMA.

Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium.

M. Welsh, J. Zabner, A. Smith, 1994, Human gene therapy.

Expanded Access of Investigational Drugs: The Experience of the Center of Drug Evaluation and Research Over a 10-Year Period

S. Khozin, Kevin Bugin, R. Moscicki, 2016, Therapeutic innovation & regulatory science.

Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment.

J. Nadol, S. Rauch, R. Moscicki, 1994, JAMA.

Serum antibodies to heat shock protein 70 in sensorineural hearing loss.

S. Rauch, R. Moscicki, D. Bloch, 1995, Archives of Otolaryngology - Head and Neck Surgery.

Treatment of Gaucher's disease.

R. Moscicki, A. Taunton-Rigby, 1993, The New England journal of medicine.

Immune-mediated inner ear disorders.

R. Moscicki, 1994, Baillière's Clinical Neurology.

Laboratory diagnosis of immune inner ear disease.

B. Barna, R. Moscicki, G. Hughes, 1994, The American journal of otology.

Impact of Expanded Access on FDA Regulatory Action and Product Labeling

R. Moscicki, J. Jarow, 2017, Therapeutic innovation & regulatory science.

Proceedings of the 2013 CINP Summit: Innovative Partnerships to Accelerate CNS Drug Discovery for Improved Patient Care

K. Krishnan, Anthony G Phillips, B. Sahakian, 2015, The international journal of neuropsychopharmacology.

Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

J. Garber, F. Wondisford, F. Brucker-Davis, 1997, The New England journal of medicine.

Adenovirus-Mediated Gene Transfer for Cystic Fibrosis: Part A. Safety of Dose and Repeat Administration in the Nasal Epithelium. Part B. Clinical Efficacy in the Maxillary Sinus. Howard Hughes Medical Institute, Iowa City, Iowa

M. Welsh, Alan E. Smith, J. Zabner, 1995 .

Securing the future of drug discovery for central nervous system disorders

R. Krishnan, Anthony G Phillips, B. Sahakian, 2014, Nature Reviews Drug Discovery.

Gaucher disease: Current issues in diagnosis and treatment

W. H. Hall, Robin E Berman, F. Collins, 1996 .